MedPath

Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

Not Applicable
Completed
Conditions
Lamotrigine
Placebo
Memnatine
Diazepam
Topiramate
Registration Number
NCT00241995
Lead Sponsor
St. Petersburg State Pavlov Medical University
Brief Summary

The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Alcohol dependence Alcohol withdrawal syndrome

Exclusion Criteria

Drug dependence Major psychiatric diagnoses Severe somatic illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath